Adaptimmune Therapeutics Plc - ADR
XNAS: ADAP
Adaptimmune Therapeutics Plc - ADR Live Stock Price Today, Share Analysis and Chart
about
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer target...
Read More
0.06
0.00
(0.00%)
49.2M
XNAS Volume
XNAS 27 Oct, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Adaptimmune Therapeutics Plc - ADR is on 13 Nov 2025 for the purpose of Adaptimmune Therapeutics PLC Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Adaptimmune Therapeutics Plc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..